Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neu status in breast cancer patients

By            

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2270-2278

Spandidos Publications

Access to resources Recommend Favorite

Her-2/ neu and Topoisomerase iiα in Breast Cancer

By Järvinen T.A.H.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 3, 2003-04 ,pp. : 299-311

Springer Publishing Company

Access to resources Recommend Favorite

Plasma Gelatinase Levels in Patients with Primary Breast Cancer in Relation to Axillary Lymph Node Status, Her2/neu Expression and other Clinicopathological Variables

By Decock J.   Hendrickx W.   Wildiers H.   Christiaens M.   Neven P.   Drijkoningen M.   Paridaens R.  

Clinical and Experimental Metastasis, Vol. 22, Iss. 6, 2005-11 ,pp. : 495-502

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy

By Falo Catalina   Moreno Abelardo   Varela Mar   Lloveras Belen   Figueras Agnès   Escobedo Agustín  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 7, 2007-07 ,pp. : 423-429

Springer Publishing Company

Access to resources Recommend Favorite

A functional polymorphism of TGFBR2 is associated with risk of breast cancer with ER+, PR+, ER+PR+ and HER2- expression in women

By                

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 653-658

Spandidos Publications

Access to resources Recommend Favorite